Interleukin‐33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage‐Mediated Shedding Mechanism

Recognition of specific antigens expressed in cancer cells is the initial process of cytolytic T cell‐mediated cancer killing. However, this process can be affected by other non‐cancerous cellular components in the tumor microenvironment. Here, it is shown that interleukin‐33 (IL‐33)‐activated macro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jing, Chen, Ziqing, Wickström, Stina L., Gao, Juan, He, Xingkang, Jing, Xu, Wu, Jieyu, Du, Qiqiao, Yang, Muyi, Chen, Yi, Zhang, Dingding, Yin, Xin, Guo, Ziheng, Jensen, Lasse, Yang, Yunlong, Tao, Wei, Lundqvist, Andreas, Kiessling, Rolf, Cao, Yihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564439/
https://www.ncbi.nlm.nih.gov/pubmed/34486239
http://dx.doi.org/10.1002/advs.202101029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564439/
https://www.ncbi.nlm.nih.gov/pubmed/34486239
http://dx.doi.org/10.1002/advs.202101029

Ejemplares similares